Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0001209191-23-027095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-03 | 2023-05-01 | NBIX | RASTETTER WILLIAM H | Dir | S - Sale+OE | $101.43 | -4,300 | 42.8K | -9% | -$436.1K |
| D | 2023-05-03 | 2023-05-01 | NBIX | RASTETTER WILLIAM H | Dir | M - OptEx | $12.71 | +7,625 | 47.1K | +19% | +$96.9K |
| D | 2023-05-03 | 2023-05-01 | NBIX | RASTETTER WILLIAM H | Dir | M - OptEx | $12.71 | -7,625 | 0 | -100% | -$96.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | S | D | 4,300 | $101.43 | 42,785 | D | — | — | (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.87 to $101.84. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. (F3) 34,022 of the reported shares are held by the Rastetter Family Trust established September 2, 2010, of which the Reporting Person has voting and investment power. |
| 2 | Common | Common Stock | 2023-05-01 | M | A | 7,625 | $12.71 | 47,085 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option | 2023-05-01 | M | D | 7,625 | $12.71 | 0 | D | $12.71 · — to 2023-05-23 | 7,625 Common Stock | (F4) The option was granted May 23, 2013 and vested in 12 equal monthly installments beginning June 23, 2013. |